Novartis AG Tries to Make UK Hospitals Use $1000 Drug Vs. Roche’s $97 Avastin

Swiss drugmaker Novartis is challenging the use of a cheap alternative to its eye drug Lucentis in parts of Britain, sparking a row over cost versus safety in treating a common cause of blindness. Luc…
Read the full story: BioSpace.com Featured News